Olivier Elemento

64.0k citations

440 papers · 25.9k indexed · 13 hit papers · h-index 80

Impact in

Cancer Research top 0.05%
- Cancer-related molecular mechanisms research
- Cancer Genomics and Diagnostics
Molecular Biology top 0.1%
- RNA modifications and cancer
- Cancer-related gene regulation
- RNA Research and Splicing
- Epigenetics and DNA Methylation
- RNA and protein synthesis mechanisms

Papers in

Cancer Research 110
- Cancer Genomics and Diagnostics 60
Health Informatics 9

Co-authors: Samie R. Jaffrey Kate D. Meyer Christopher E. Mason Yogesh Saletore Paul Zumbo Saeed Tavazoie Ευγενία Γιαννοπούλου Neel S. Madhukar
Journals: Blood (35 papers)Cancer Research (26 papers)Journal of Clinical Oncology (19 papers)Nature Communications (19 papers)Cell Reports (16 papers)
Partner nations: United States Israel Italy

In The Last Decade

Olivier Elemento

412 papers receiving 25.6k citations

Hit Papers

13 papers align trajectories log scale

Artificial Intelligence in Cancer Research and Precision Medicine 2021 · 417 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2021 Cancer Discovery
2021 Nature
2021 The Lancet Oncology
2019 npj Digital Medicine
2019 Briefings in Bioinformatics
2019 European Journal of Cancer
2019 Nature Medicine
2016 Nature
2016 Nature Medicine
2015 Science
2015 Cell
2013 Developmental Cell
2012 Cell

Peers

Countries citing papers authored by Olivier Elemento

Since Specialization

Citations

This map shows the geographic impact of Olivier Elemento's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Olivier Elemento with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Olivier Elemento more than expected).

Fields of papers citing papers by Olivier Elemento

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Olivier Elemento. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Olivier Elemento. The network helps show where Olivier Elemento may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Olivier Elemento, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Olivier Elemento Line = papers co-authored together Olivier Elemento links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Enhancing the detection of clinically relevant biomarkers in advanced uterine and tubo-ovarian carcinomas through genome-wide analysis Pathology - Research and Practice ·Jie Zhang, Kevin Hadi, Jiangling Tu, Max F. Levine, Minal Patel, Aditya Deshpande, Vikrant Bhalerao, Michael Sigouros, Andrea Sboner, Eloise Chapman‐Davis, Olivier Elemento, Kevin Holcomb, Bariş Boyraz, Juan Miguel Mosquera	2024	1
2	The power and perils of large language models in haematology British Journal of Haematology ·Jacob L. Glass, Olivier Elemento	2024	0
3	Whole-Genome Sequencing Analysis of Male Breast Cancer Unveils Novel Structural Events and Potential Therapeutic Targets Modern Pathology ·Jie Zhang, Jinbing Ha, K. Cabrera-Luna, Michael Sigouros, M. E. Losi, Andy V. Phan, Max F. Levine, Gunes Gundem, Juan S. Medina-Martínez, Elli Papaemmanuil, Vikrant Bhalerao, David Wilkes, Andrea Sboner, Syed A. Hoda, Olivier Elemento, Juan Miguel Mosquera	2024	5
4	TIMP1 is an early biomarker for detection and prognosis of lung cancer Clinical and Translational Medicine ·Ezequiel Dantas, 直明池田, Tanvir Ahmed, 解维汉, Shakti Ramsamooj, Guang Ling He, Tiffany Lam, Murtaza Malbari, S Shabina, Olivier Elemento, Ianir Milevski, Darryl Pappin, Timothy E. McGraw, Brendon M. Stiles, Nasser K. Altorki, Marcus D. Goncalves	2023	19
5	Discovery of Candidate DNA Methylation Cancer Driver Genes Cancer Discovery ·Heng Pan, Loïc Renaud, Ronan Chaligné, Johannes Bloehdorn, Eugen Tausch, Daniel Mertens, Anna Maria Fink, Kirsten Fischer, Chao Zhang, Doron Betel, Andreas Gnirke, Marcin Imieliński, Jérôme Moreaux, Michael Hallek, Alexander Meissner, Stephan Stilgenbauer, Catherine J. Wu, Olivier Elemento, Dan A. Landau	2021	53
6	Systems biology analysis of human genomes points to key pathways conferring spina bifida risk Proceedings of the National Academy of Sciences ·Vanessa Aguiar‐Pulido, Gabriela Paulino Vilela, Alexander Martinez‐Fundichely, Eran Elhaik, Gaurav Thareja, 吕金光 LV Jin-guang, Nader Chalhoub, Tawny N. Cuykendall, Mia Gyn Tudtud -, Yunping Lei, Bondarenko M., James M. Musser, Alessandra Calì, Gary M. Shaw, Ekta Khurana, Karsten Suhre, Christopher E. Mason, Olivier Elemento, Richard H. Finnell, M. Elizabeth Ross	2021	10
7	High-resolution mouse subventricular zone stem-cell niche transcriptome reveals features of lineage, anatomy, and aging Proceedings of the National Academy of Sciences ·Xuanhua Xie, Dan R. Laks, Daochun Sun, Asaf Poran, Ashley M. Laughney, Zilai Wang, 杨仁伟, Germán Belenguer, Isabel Fariñas, Olivier Elemento, Xiuping Zhou, Luis F. Parada	2020	39
8	The INPP4B Tumor Suppressor Modulates EGFR Trafficking and Promotes Triple-Negative Breast Cancer Cancer Discovery ·Hui Liu, Marcia N. Paddock, Haibin Wang, Charles J. Murphy, Renee C. Geck, Thrush Dl, Gerburg M. Wulf, Olivier Elemento, Volker Haucke, Lewis C. Cantley, Alex Toker	2020	42
9	The Transcriptional Regulator Sin3A Contributes to the Oncogenic Potential of STAT3 Cancer Research ·Giovanni Gambi, С. В. Иванов, Veronica Basso, Luisa Ricci, Rui Wang, Akanksha Verma, Olivier Elemento, Maurilio Ponzoni, Giorgio Inghirami, Laura Icardi, Anna Mondino	2019	30
10	Precision Targeting with EZH2 and HDAC Inhibitors in Epigenetically Dysregulated Lymphomas Clinical Cancer Research ·Jennifer Kimberly Lue, Sathyen A. Prabhu, Yuxuan Liu, Mariana Castro Muñetón, Akanksha Verma, Prabhjot S. Mundi, Nebiyu Abshiru, Jeannie M. Camarillo, ET Habermann, Christian Thier, William Lawhorn, Renu Nandakumar, Serge Cremers, Neil L. Kelleher, Olivier Elemento, Jennifer E. Amengual	2019	59
11	EthSEQ: ethnicity annotation from whole exome sequencing data Bioinformatics ·Alessandro Romanel, Tuo Zhang, Olivier Elemento, Francesca Demichelis	2017	20
12	Identifying and Targeting Sporadic Oncogenic Genetic Aberrations in Mouse Models of Triple-Negative Breast Cancer Cancer Discovery ·Hui Liu, Charles J. Murphy, Florian A. Karreth, Kristina B. Emdal, Forest M. White, Olivier Elemento, Alex Toker, Gerburg M. Wulf, Lewis C. Cantley	2017	49
13	Mechanisms of Acquired Drug Resistance to the HDAC6 Selective Inhibitor Ricolinostat Reveals Rational Drug-Drug Combination with Ibrutinib Clinical Cancer Research ·Jennifer E. Amengual, Sathyen A. Prabhu, Maximilian Lombardo, Kelly Zullo, Paul Johannet, Mariana Castro Muñetón, Luigi Scotto, G. Izawa, Alicia Ottosson, Jimmy Duong, Renu Nandakumar, Serge Cremers, Akanksha Verma, Olivier Elemento, Owen A. O’Connor	2016	24
14	The cancer precision medicine knowledge base for structured clinical-grade mutations and interpretations Journal of the American Medical Informatics Association ·Linda Huang, Helen Fernandes, 博明今村, Peyman Tavassoli, Hanna Rennert, David J. Pisapia, Marcin Imieliński, Andrea Sboner, Mark A. Rubin, Michael Kluk, Olivier Elemento	2016	67
15	Vitamin C selectively kills KRAS and BRAF mutant colorectal cancer cells by targeting GAPDH Science ·Jihye Yun, Edouard Mullarky, Miguel Alejandro Herszenbaun, Kaitlyn Bosch, Adam Kavalier, Keith Rivera, Jatin Roper, Iok In Christine Chio, Ευγενία Γιαννοπούλου, Carlo Rago, Ashlesha Muley, John M. Asara, Jihye Paik, Olivier Elemento, Zhengming Chen, Darryl Pappin, Lukas E. Dow, Nickolas Papadopoulos, Steven S. Gross, Lewis C. Cantley Hit paper breakdown →	2015	696
16	A Virtual B Cell Lymphoma Model to Predict Effective Combination Therapy Blood ·Wei Du, Rebecca Goldstein, Yanwen Jiang, 高森功, Leandro Cerchietti, Ari Melnick, Olivier Elemento	2014	1
17	Cell-Cycle Reprogramming for PI3K Inhibition Overrides a Relapse-Specific C481S BTK Mutation Revealed by Longitudinal Functional Genomics in Mantle Cell Lymphoma Cancer Discovery ·David Chiron, Maurizio Di Liberto, Peter Martin, Xiangao Huang, Jeff P. Sharman, Pedro Blecua, Susan Mathew, Priyanka Vijay, Ken Eng, Siraj M. Ali, Amy J. Johnson, Betty Chang, Scott Ely, Olivier Elemento, Christopher E. Mason, John P. Leonard, Selina Chen‐Kiang	2014	204
18	Metabolic Alterations in Lung Cancer–Associated Fibroblasts Correlated with Increased Glycolytic Metabolism of the Tumor Molecular Cancer Research ·Virendra K. Chaudhri, Б Д Руденко, Yasuhi Uehara, Ofelia Alencastre Mamani, Raffaella Sordella, Edward D. Karoly, Robert P. Mohney, Brendon M. Stiles, Olivier Elemento, Nasser K. Altorki, Timothy E. McGraw	2013	77
19	A Panel of Four miRNAs Accurately Differentiates Malignant from Benign Indeterminate Thyroid Lesions on Fine Needle Aspiration Clinical Cancer Research ·Xavier M. Keutgen, Filippo Filicori, Michael J. Crowley, Yongchun Wang, Theresa Scognamiglio, Rana S. Hoda, Daniel Buitrago, David M. L. Cooper, Martha A. Zeiger, Rasa Zarnegar, Olivier Elemento, Thomas J. Fahey	2012	123
20	Epigenetic Repression of miR-31 Disrupts Androgen Receptor Homeostasis and Contributes to Prostate Cancer Progression Cancer Research ·Pei‐Chun Lin, Ya‐Lin Chiu, Samprit Banerjee, Kyung Park, Juan Miguel Mosquera, Ευγενία Γιαννοπούλου, Pedro Alves, Ashutosh Tewari, Mark Gerstein, Himisha Beltran, Ari Melnick, Olivier Elemento, Francesca Demichelis, Mark A. Rubin	2012	144

About Olivier Elemento

Olivier Elemento is a scholar working on Cancer Research, Health Informatics, Oncology, Molecular Biology and Pathology and Forensic Medicine, having authored 440 papers that have together received 25.9k indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (60 papers), Epigenetics and DNA Methylation (44 papers), Lymphoma Diagnosis and Treatment (34 papers), Genomics and Chromatin Dynamics (28 papers), Prostate Cancer Treatment and Research (27 papers), RNA modifications and cancer (26 papers), Cancer-related gene regulation (26 papers) and RNA Research and Splicing (26 papers). The work is most often cited by research in Cancer Research (6.4k citations), Molecular Biology (16.5k citations), Health Informatics (313 citations), Oncology (4.3k citations) and Immunology (3.0k citations). Olivier Elemento has collaborated with scholars based in United States, Israel and Italy. Frequent co-authors include Samie R. Jaffrey, Kate D. Meyer, Christopher E. Mason, Yogesh Saletore, Paul Zumbo, Saeed Tavazoie, Ευγενία Γιαννοπούλου, Neel S. Madhukar, Deepak P. Patil and Ari Melnick. Their work appears in journals such as Blood, Cancer Research, Journal of Clinical Oncology, Nature Communications and Cell Reports.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact